This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Nexstim Past Earnings Performance
Past criteria checks 3/6
Key information
42.4%
Earnings growth rate
79.1%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 34.5% |
| Return on equity | 32.1% |
| Net Margin | 12.1% |
| Next Earnings Update | 18 Aug 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Nexstim makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 11 | 1 | 5 | 0 |
| 30 Sep 22 | 11 | 2 | 5 | 0 |
| 30 Jun 22 | 12 | 3 | 5 | 0 |
| 31 Mar 22 | 10 | 1 | 5 | 0 |
| 31 Dec 21 | 8 | -1 | 5 | 0 |
| 30 Sep 21 | 7 | -2 | 5 | 0 |
| 30 Jun 21 | 6 | -4 | 4 | 0 |
| 31 Mar 21 | 5 | -4 | 4 | 0 |
| 31 Dec 20 | 4 | -4 | 4 | 0 |
| 30 Sep 20 | 4 | -4 | 4 | 0 |
| 30 Jun 20 | 4 | -4 | 5 | 0 |
| 31 Mar 20 | 4 | -6 | 5 | 0 |
| 31 Dec 19 | 3 | -7 | 5 | 0 |
| 30 Sep 19 | 3 | -7 | 5 | 0 |
| 30 Jun 19 | 3 | -7 | 5 | 0 |
| 31 Mar 19 | 3 | -7 | 5 | 0 |
| 31 Dec 18 | 3 | -6 | 4 | 0 |
| 30 Sep 18 | 3 | -6 | 4 | 0 |
| 30 Jun 18 | 3 | -6 | 4 | 0 |
| 31 Mar 18 | 3 | -7 | 4 | 0 |
| 31 Dec 17 | 3 | -7 | 4 | 0 |
| 30 Sep 17 | 3 | -7 | 4 | 0 |
| 30 Jun 17 | 3 | -6 | 4 | 0 |
| 31 Mar 17 | 3 | -6 | 4 | 0 |
| 31 Dec 16 | 3 | -7 | 4 | 0 |
| 30 Sep 16 | 3 | -8 | 4 | 0 |
| 30 Jun 16 | 3 | -9 | 4 | 0 |
Quality Earnings: NXTMS has a high level of non-cash earnings.
Growing Profit Margin: NXTMS became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NXTMS has become profitable over the past 5 years, growing earnings by 42.4% per year.
Accelerating Growth: NXTMS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: NXTMS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-5.6%).
Return on Equity
High ROE: NXTMS's Return on Equity (32.1%) is considered high.